The Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece, and the European Infrastructure for Translational Medicine (EATRIS) are pleased to announce the signing of a Memorandum of Understanding (MoU) that marks a major milestone towards Greece’s potential prospective observership/membership in EATRIS.
The MoU formalises the commitment of both parties to foster collaboration and coordination in promoting the benefits of Greece’s potential membership in EATRIS among national research institutions. The agreement encompasses various activities aimed at enhancing translational research capabilities and driving progress in the field of personalised medicine in Greece.
Key aspects of the MoU include promoting EATRIS visibility, where both parties will collaborate to raise awareness of the advantages of joining EATRIS within the Greek research community. Additionally, efforts will be undertaken to coordinate the formation of a national consortium of translational research institutions in Greece, with the aim of supporting Greece’s observership/membership in EATRIS. Furthermore, the Biomedical Research Foundation of the Academy of Athens and EATRIS will join forces with EATRIS to organise and participate in relevant events, ensuring active engagement with the national research landscape and industry.
Toni Andreu (Scientific Director at EATRIS) expressed his enthusiasm for the MoU, stating: “This MoU represents a significant step forward in our mission to advance translational research across Europe. We are excited to collaborate with the Biomedical Research Foundation of the Academy of Athens and are confident that this partnership will contribute greatly to the growth and success of translational medicine in Greece. Ultimately, it is patients that will benefit.”
Konstantinos Tamvakopoulos (Research Director of Pharmacology at the Biomedical Research Foundation of the Academy of Athens) added: “This is a great opportunity for Greece and BRFAA to enhance its translational research capabilities. This MoU underscores our commitment to strengthening the Greek scientific community’s engagement in translational research and personalised medicine.”
Both parties look forward to a productive and fruitful collaboration that will benefit the Greek scientific community and contribute to EATRIS’ mission to accelerate the translation of scientific discoveries into benefits for patients.
About EATRIS:
EATRIS is the European infrastructure for translational medicine that brings together resources and services for research communities to translate scientific discoveries into benefits for patients. The organisation is a non-profit that provides access to a vast array of expertise and facilities from over 150 top-tier academic centres across Europe. EATRIS focuses on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcoming barriers to health innovation. www.eatris.eu
About the Biomedical Research Foundation of the Academy of Athens:
The Biomedical Research Foundation of the Academy of Athens is a leading research institution in Greece that aims to achieve excellence in basic and clinical research, paving the path for translational research and precision medicine. www.bioacademy.gr
For media inquiries, please contact:
EATRIS
Dr Jake Fairnie
Email: jakefairnie@eatris.eu
